PREFACE: Antiepileptogenesis following traumatic brain injury

TY - JOUR

T1 - PREFACE

T2 - Antiepileptogenesis following traumatic brain injury

AU - Galanopoulou, Aristea S.

AU - Engel, Jerome

AU - Moshé, Solomon L.

N1 - Funding Information: ASG acknowledges grant support by NINDS RO1 NS091170, the NINDS Center without Walls U54 NS100064 (EpiBioS4Rx), the United States Department of Defense ( W81XWH-13-1-0180 ), research funding from the Heffer Family, the Segal Family Foundations and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. ASG has received royalties for publications from Elsevier and a one-time honorarium for participation at a scientific advisory board for Mallinckrodt and is a co-Editor-in-Chief at Epilepsia Open but has no conflicts in regards to this article. Funding Information: SLM is the Charles Frost Chair in Neurosurgery and Neurology and partially funded by grants from NIHU54 NS100064 and NS43209, United States Department of Defense ( W81XWH-13-1-0180 ), and the Heffer Family and the Segal Family Foundations and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. S.L.M. has no conflicts of interest in regards to this article. He is serving as Associate Editor of Neurobiology of Disease and is on the editorial board of Brain and Development, Pediatric Neurology and Physiological Research. He receives from Elsevier an annual compensation for his work as Associate Editor in Neurobiology of Disease and royalties from 2 books he co-edited. He received a consultant fee from UCB for participation in a DSMB. He has also received honorarium for participation in an advisory board meeting of Mallinckrodt, but there is no conflict of interest in regards to the contents of this manuscript. Funding Information: SLM is the Charles Frost Chair in Neurosurgery and Neurology and partially funded by grants from NIHU54 NS100064 and NS43209, United States Department of Defense (W81XWH-13-1-0180), and the Heffer Family and the Segal Family Foundations and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. S.L.M. has no conflicts of interest in regards to this article. He is serving as Associate Editor of Neurobiology of Disease and is on the editorial board of Brain and Development, Pediatric Neurology and Physiological Research. He receives from Elsevier an annual compensation for his work as Associate Editor in Neurobiology of Disease and royalties from 2 books he co-edited. He received a consultant fee from UCB for participation in a DSMB. He has also received honorarium for participation in an advisory board meeting of Mallinckrodt, but there is no conflict of interest in regards to the contents of this manuscript. Funding Information: JE acknowledges research funding from the National Institutes of Health grant numbers NS-002808 , NS-015654 , NS-033310 , NS-042372 , and NINDS Center without Walls, U54 NS100064 (EpiBioS4Rx). Funding Information: ASG acknowledges grant support by NINDS RO1 NS091170, the NINDS Center without Walls U54 NS100064 (EpiBioS4Rx), the United States Department of Defense (W81XWH-13-1-0180), research funding from the Heffer Family, the Segal Family Foundations and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. ASG has received royalties for publications from Elsevier and a one-time honorarium for participation at a scientific advisory board for Mallinckrodt and is a co-Editor-in-Chief at Epilepsia Open but has no conflicts in regards to this article.JE acknowledges research funding from the National Institutes of Health grant numbers NS-002808, NS-015654, NS-033310, NS-042372, and NINDS Center without Walls, U54NS100064 (EpiBioS4Rx).SLM is the Charles Frost Chair in Neurosurgery and Neurology and partially funded by grants from NIHU54 NS100064 and NS43209, United States Department of Defense (W81XWH-13-1-0180), and the Heffer Family and the Segal Family Foundations and the Abbe Goldstein/Joshua Lurie and Laurie Marsh/Dan Levitz families. S.L.M. has no conflicts of interest in regards to this article. He is serving as Associate Editor of Neurobiology of Disease and is on the editorial board of Brain and Development, Pediatric Neurology and Physiological Research. He receives from Elsevier an annual compensation for his work as Associate Editor in Neurobiology of Disease and royalties from 2 books he co-edited. He received a consultant fee from UCB for participation in a DSMB. He has also received honorarium for participation in an advisory board meeting of Mallinckrodt, but there is no conflict of interest in regards to the contents of this manuscript.

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85054695043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054695043&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2018.10.003

DO - 10.1016/j.nbd.2018.10.003

M3 - Editorial

C2 - 30312758

AN - SCOPUS:85054695043

SN - 0969-9961

VL - 123

SP - 1

EP - 2

JO - Neurobiology of Disease

JF - Neurobiology of Disease

ER -